96 results
Page 2 of 5
8-K
EX-99.1
jz7rrb4c3el484709o
10 Nov 21
Adicet Reports Third Quarter 2021 Financial Results and Provides Business Updates
4:12pm
8-K
ttsi4
13 Sep 21
Regulation FD Disclosure
8:14am
8-K
EX-99.1
oqd 4wguf
13 Sep 21
Regulation FD Disclosure
8:14am
8-K
EX-99.1
9fjvawmduot0ibab7759
10 Mar 21
Adicet Bio Announces Initiation of its First-in-Human Phase 1 Trial of ADI-001 for Company’s lead candidate, ADI-001, is believed to be the first IND-cleared allogeneic
7:30am
424B5
kj5v4
11 Feb 21
Prospectus supplement for primary offering
5:20pm
424B5
7uxe6ons2qq3h1ay97l
10 Feb 21
Prospectus supplement for primary offering
12:00am
424B5
l6s5s
1 Dec 20
Prospectus supplement for primary offering
5:28pm
8-K
EX-99.1
p5iu5xqxuycj0
22 Oct 20
Adicet Announces FDA Clearance of IND Application for First-in-Class Allogeneic CAR Gamma-Delta T Cell Therapy
7:15am
424B5
e6qhf1
21 Sep 20
Prospectus supplement for primary offering
7:58am
8-K
EX-99.1
uvvmfdtptz79mwqrj
18 Sep 20
Management Following the Merger
4:30pm
8-K
EX-99.6
ar5hrr29 cudk3
16 Sep 20
Entry into a Material Definitive Agreement
9:59am
8-K
EX-99.5
bmg7m0tuabgi789
16 Sep 20
Entry into a Material Definitive Agreement
9:59am